Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer.

MLA

Kinkead, Heather L., et al. “Combining STING-Based Neoantigen-Targeted Vaccine with Checkpoint Modulators Enhances Antitumor Immunity in Murine Pancreatic Cancer.” JCI Insight, vol. 3, no. 20, Oct. 2018. EBSCOhost, https://doi.org/10.1172/jci.insight.122857.

APA

Kinkead, H. L., Hopkins, A., Lutz, E., Wu, A. A., Yarchoan, M., Cruz, K., Woolman, S., Vithayathil, T., Glickman, L. H., Ndubaku, C. O., McWhirter, S. M., Dubensky, T. W., Jr, Armstrong, T. D., Jaffee, E. M., & Zaidi, N. (2018). Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer. JCI Insight, 3(20). https://doi.org/10.1172/jci.insight.122857

Chicago

Kinkead, Heather L, Alexander Hopkins, Eric Lutz, Annie A Wu, Mark Yarchoan, Kayla Cruz, Skylar Woolman, et al. 2018. “Combining STING-Based Neoantigen-Targeted Vaccine with Checkpoint Modulators Enhances Antitumor Immunity in Murine Pancreatic Cancer.” JCI Insight 3 (20). doi:10.1172/jci.insight.122857.